Amyloid: The Journal of Protein Folding Disorders

Amyloid: The Journal of Protein Folding Disorders is the quarterly journal of the International Society of Amyloidosis, published by Taylor & Francis and founded in 1994, carrying basic, clinical and epidemiological work on amyloid fibrils and the amyloidoses, with a 2025 Journal Impact Factor of 5.1 (formerly carried in the library under the entry name Amyloid-journal of Protein Folding Disorders).《淀粉样变-蛋白质折叠疾病杂志》（Amyloid: The Journal of Protein Folding Disorders）是国际淀粉样变性学会的官方季刊，由（Taylor & Francis）出版，1994 年创刊，刊载淀粉样纤维与各类淀粉样变性的基础、临床和流行病学研究，2025 年期刊影响因子为 5.1（库内原题名为 Amyloid-journal of Protein Folding Disorders）。

Scope

• Etiology of the amyloidoses and of the precursor proteins that generate amyloid fibrils.淀粉样变性的病因学，以及生成淀粉样纤维的前体蛋白。
• Epidemiology of systemic and localized forms, including hereditary and wild-type transthyretin amyloidosis.系统性与局部性淀粉样变的流行病学，包括遗传型与野生型转甲状腺素蛋白淀粉样变。
• Genetics of the hereditary disorders, from transthyretin and fibrinogen A alpha-chain variants to apolipoprotein mutations.遗传型疾病的遗传学，从转甲状腺素蛋白与纤维蛋白原 A α 链变异到载脂蛋白突变。
• Pathogenesis, covering chemical structure, fibrillogenesis and the mechanism by which deposits damage organs.发病机制，涵盖化学结构、纤维生成以及沉积物损伤器官的机制。
• Pathology and histopathology of tissue deposits, including typing of the amyloid protein in biopsy material.组织沉积物的病理学与组织病理学，包括活检标本中的淀粉样蛋白分型。
• Diagnosis, treatment and prognosis across the specialties that amyloid disease touches, notably haematology, cardiology, neurology and nephrology.淀粉样变所涉各专科的诊断、治疗与预后，尤以血液科、心脏科、神经科与肾科为主。
• Other disorders of abnormal protein folding, plus the journal's own mix of research articles, letters to the Editor, review articles and invited commentaries.其他异常蛋白折叠疾病，以及本刊固定的研究论文、致编辑信、综述与约稿评论等体裁。

History

• Volume 1, number 1 appeared in March 1994, when the International Society of Amyloidosis launched the title with Parthenon Publishing of Pearl River, New York, and the opening editorial was titled The origins of Amyloid.第 1 卷第 1 期于 1994 年 3 月出版，由国际淀粉样变性学会与纽约珍珠河的（Parthenon Publishing）共同创办，开篇社论题为《淀粉样蛋白的起源》。^[1]

• The subtitle Journal of Protein Folding Disorders was already in use by 2001, and the publisher now cites the journal as Amyloid: The Journal of Protein Folding Disorders.副题（Journal of Protein Folding Disorders）至 2001 年已在使用，出版方现以（Amyloid: The Journal of Protein Folding Disorders）作为正式刊名。
• Ownership of the title passed from Parthenon to the Taylor & Francis group, which has published the journal from Abingdon, Oxford, since 2015.刊物的出版权由（Parthenon）转入（Taylor & Francis）集团，自 2015 年起由后者在牛津郡阿宾登出版。
• It has stayed a quarterly throughout, with four issues a year and volume 32 completed in 2025.刊物始终为季刊，每年 4 期，2025 年出齐第 32 卷。
• MEDLINE and PubMed have indexed it since volume 5, number 1 in 1998, alongside Science Citation Index Expanded, Scopus, Embase, BIOSIS Previews and Current Contents.自 1998 年第 5 卷第 1 期起被（MEDLINE）与（PubMed）收录，同时进入（Science Citation Index Expanded）、（Scopus）、（Embase）、（BIOSIS Previews）与（Current Contents）。
• The 2025 Journal Impact Factor is 5.1, after 7.4 in 2024, 6.571 in 2022 and 7.141 in 2021, which puts it in Q1 of medicine, general and internal at rank 42 of 336.2025 年期刊影响因子为 5.1，2024 年为 7.4，2022 年为 6.571，2021 年为 7.141，在医学综合与内科学类别位列 Q1，排名 42/336。

Editors

• Shaji Kumar, Mark and Judy Mullins Professor of Hematological Malignancies at Mayo Clinic in Rochester, Minnesota, leads the journal as editor-in-chief and marked the handover with a December 2025 editorial.明尼苏达州罗切斯特（Mayo Clinic）的（Shaji Kumar）以主编身份主持本刊，并以 2025 年 12 月的一篇社论标志这次交接。^[2]
• The same editorial pays tribute to Per Westermark, the outgoing editor-in-chief, so the title changed hands at the end of 2025.该社论同时向前任主编（Per Westermark）致敬，刊物由此在 2025 年底完成主编更替。
• The journal is Open Select, meaning subscription publication remains the default while authors may pay to make their own article gold open access.本刊采用（Open Select）模式，默认仍按订阅制发表，作者可付费将单篇文章转为金色开放获取。
• Manuscripts reach the editorial office through the publisher's online submission site, and invited commentaries are normally commissioned rather than volunteered.稿件经出版方的在线投稿系统进入编辑部，评论文章通常由编辑部约稿而非自由投稿。
• Because the journal is indexed in MEDLINE and PubMed, its case series and treatment reports reach haematology, cardiology and neurology clinics directly.由于被（MEDLINE）与（PubMed）收录，本刊的病例系列与治疗报告可直接进入血液科、心脏科与神经科的临床视野。